ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Working Group Beings AID-Related Lymphoma research

October 19, 1990

DeVita Heads U.S. Board Of CCCR

August 4, 1989

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

Medicare Cuts Proposed In budget reduction Amendment For FY94

November 19, 1993

Breast Cancer Task Force Reorganized, Foiled By Snow

March 2, 1979

ASCO Report Urges 5% Annual Increase For NIH.

December 8, 2006